Netivudine

N/A

Report date: 2022/12/07 17:52:22

NME

Base Information

Drug NameNetivudine

Drug Alias Name882C87BW-882882C5PU

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsChickenpoxHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsChickenpoxHIV Infections

ATC CodeN/A